This inventor holds 4 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignees: Technion Research & Development Foundation Ltd, Taro Pharmaceutical Industries Limited. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,004 
1 out of 38 Years Active: 2015-2018
Title: Igor Nudelman: Innovator in Genetic Disorder Treatments
Introduction
Igor Nudelman is a prominent inventor based in Haifa, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of genetic disorders. With a total of 4 patents to his name, Nudelman has developed innovative solutions that address critical health challenges.
Latest Patents
Nudelman's latest patents include groundbreaking work on aminoglycosides and their uses in treating genetic disorders. This new class of paromomycin-derived aminoglycosides demonstrates efficient stop-codon mutation suppression activity, low toxicity, and high selectivity towards eukaryotic cells. Additionally, he has provided chemical and chemo-enzymatic processes for preparing these aminoglycosides and their intermediates, along with pharmaceutical compositions for their application in genetic disorder treatments. Another notable patent involves an improved process for preparing 17-desoxy corticosteroid derivatives. This process allows for the synthesis of these derivatives in a single chemical step by reacting the 17-hydroxy starting material with an excess of Trimethylsilyl Iodide, which is particularly advantageous for creating derivatives with halogen groups.
Career Highlights
Throughout his career, Igor Nudelman has worked with esteemed organizations such as Technion Research & Development Foundation Limited and Taro Pharmaceutical Industries Limited. His work has significantly impacted the pharmaceutical industry, particularly in developing treatments for genetic disorders.
Collaborations
Nudelman has collaborated with notable colleagues, including Timor Baasov and Tamar Ben-Yosef. These partnerships have fostered innovation and contributed to the advancement of his research.
Conclusion
Igor Nudelman's contributions to the field of pharmaceuticals, particularly in genetic disorder treatments, highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile